Ribon Therapeutics Raises $65 Million to Advance Pipeline of NovelTherapeutics Targeting Cellular Stress Pathways for Cancer

from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2H5Al7I
via IFTTT